0.6499
price down icon2.77%   -0.0185
after-market 시간 외 거래: .65 0.000100 +0.02%
loading

Invivyd Inc 주식(IVVD)의 최신 뉴스

pulisher
Apr 23, 2025

What is Invivyd Inc (IVVD) Stock Return on Shareholders’ Capital? - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Guggenheim upgrades Invivyd Inc (IVVD) rating to a Buy - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms - Endpoints News

Apr 22, 2025
pulisher
Apr 22, 2025

IVVD Stock Price and Chart — NASDAQ:IVVD - TradingView

Apr 22, 2025
pulisher
Apr 22, 2025

Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Ba - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Invivyd Inc (IVVD) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 22, 2025
pulisher
Apr 21, 2025

Invivyd secures $30 million loan for COVID-19 antibody development By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 21, 2025

What's Going On With Invivyd Stock On Monday? - AOL.com

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Announces $30 Million Loan Facility With Silicon Valley Bank - citybiz

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd (IVVD) Secures $30 Million Loan Facility from Silicon Valley Bank - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd gets $30M term loan facility from Silicon Valley Bank - MSN

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Secures $30 Million Loan from SVB - TipRanks

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd (IVVD) Secures $30M Loan Facility from Silicon Valley Bank | FCNCA Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Enters $30 Mln Term Loan Facility With Silicon Valley Bank - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd secures $30 million loan for COVID-19 antibody development - Investing.com

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd, Inc. Secures $30 Million Term Loan Facility from Silicon Valley Bank to Advance Viral Infectious Disease Pipeline - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Invivyd Lands Strategic $30M Financing Deal: What This Means for VYD2311's FDA Journey - Stock Titan

Apr 21, 2025
pulisher
Apr 15, 2025

Invivyd - WACH

Apr 15, 2025
pulisher
Apr 09, 2025

Invivyd Inc (NASDAQ: IVVD) – Analysts’ Views Revised To A Positive - stocksregister.com

Apr 09, 2025
pulisher
Apr 03, 2025

Invivyd, Inc. (NASDAQ:IVVD) Sees Large Drop in Short Interest - MarketBeat

Apr 03, 2025
pulisher
Mar 27, 2025

Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

Invivyd Appoints Ajay Royan to its Board of Directors - citybiz

Mar 27, 2025
pulisher
Mar 26, 2025

Invivyd adds venture capitalist Ajay Royan to board By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Invivyd Appoints Ajay Royan to Board of Directors - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Invivyd adds venture capitalist Ajay Royan to board - Investing.com India

Mar 26, 2025
pulisher
Mar 23, 2025

Invivyd’s (IVVD) Buy Rating Reiterated at D. Boral Capital - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI - Business Wire

Mar 21, 2025
pulisher
Mar 21, 2025

Invivyd Reports Strong Revenue Growth and Promising Developments - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Invivyd earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 -March 20, 2025 at 08:12 am EDT - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights - The Manila Times

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Reports 48% Q4 Revenue Growth for PEMGARDA™ and Advances Next-Generation Antibody VYD2311 - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd, Inc. Full Year Loss Decreases, But Misses Estimates - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Invivyd (IVVD) Projected to Post Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 12, 2025

Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 06, 2025

D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - MarketBeat

Mar 06, 2025
pulisher
Mar 05, 2025

Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd reports pemivibart maintains efficacy against SARS-CoV-2 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1 - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

Invivyd's COVID Treatment Still Works Against Elusive LP.8.1 VariantCritical News for Immunocompromised Patients - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

Invivyd (NasdaqGM:IVVD) Jumps 163% After Promising Phase 1/2 Trial Results For COVID-19 Antibody - Simply Wall St

Mar 04, 2025
pulisher
Mar 04, 2025

Invivyd Inc [IVVD] Insider Activity: An Update for Investors - Knox Daily

Mar 04, 2025
pulisher
Mar 04, 2025

Invivyd Inc’s Banking’s 100-Day Moving Average at 0.8392: Will the Stock Break Through? - investchronicle.com

Mar 04, 2025
pulisher
Mar 02, 2025

Why Invivyd, Inc. (IVVD) is Skyrocketing So Far in 2025 - Insider Monkey

Mar 02, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 26, 2025

D. Boral Capital Reiterates “Buy” Rating for Invivyd (NASDAQ:IVVD) - Armenian Reporter

Feb 26, 2025
pulisher
Feb 25, 2025

The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Invivyd (NASDAQ:IVVD) Receives “Buy” Rating from D. Boral Capital - Defense World

Feb 25, 2025
pulisher
Feb 25, 2025

Invivyd (NASDAQ:IVVD) Given “Buy” Rating at HC Wainwright - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

FDA declines Invivyd's COVID-19 treatment EUA expansion By Investing.com - Investing.com Australia

Feb 24, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):